Skip to Main Content

Paper Details

Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Blood
40
2022
228 genes, AML, CHEK2, DDX41, DNA damage response genes, DNAH5, DNAH9, DNMT3A, P/LP germline variants, SUZ12, TAPES, candidate genes, germline, germline variants, hematological malignancies, leukemia, myeloid malignancies, myeloid malignancy, patients
Age Factors, Aged, Female, Genetic Predisposition to Disease, Germ-Line Mutation, Humans, Leukemia, Myeloid, Acute, Male, Middle Aged, Neoplasm Proteins
Author NameAffiliation
Fei Yang
Fei YangKnight Cancer Institute, Oregon Health & Science University
Nicola LongKnight Cancer Institute, Oregon Health & Science University
Tauangtham Anekpuritanang
Tauangtham AnekpuritanangKnight Cancer Institute, Oregon Health & Science University
Tauangtham AnekpuritanangFaculty of Medicine Siriraj Hospital, Mahidol University
Daniel BottomlyKnight Cancer Institute, Oregon Health & Science University
Daniel Bottomly
Jonathan C SavageKnight Cancer Institute, Oregon Health & Science University
Jonathan C SavageOregon Health & Science University
Tiffany LeeKnight Cancer Institute, Oregon Health & Science University
Jose Solis-RuizKnight Cancer Institute, Oregon Health & Science University
Uma BorateKnight Cancer Institute, Oregon Health & Science University
Beth WilmotKnight Cancer Institute, Oregon Health & Science University
Beth Wilmot
Cristina E TognonKnight Cancer Institute, Oregon Health & Science University
Allison M BockUniversity of Colorado
Daniel A PollyeaUniversity of Colorado
Saikripa M RadhakrishnanUniversity of Texas Southwestern Medical Center
Srinidhi RadhakrishnanUniversity of Texas Southwestern Medical Center
Prapti PatelUniversity of Texas Southwestern Medical Center
Robert H CollinsUniversity of Texas Southwestern Medical Center
Srinivas K TantravahiUniversity of Utah Huntsman Cancer Institute
Michael W DeiningerUniversity of Utah Huntsman Cancer Institute
Guang Fan
Guang FanKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Ujwal ShindeKnight Cancer Institute, Oregon Health & Science University
Ujwal ShindeOregon Health & Science University
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University
Jeffrey W Tyner
Richard D Press
Richard D PressKnight Cancer Institute, Oregon Health & Science University
Shannon K McWeeneyKnight Cancer Institute, Oregon Health & Science University
Shannon K McWeeney
Anupriya AgarwalKnight Cancer Institute, Oregon Health & Science University
Anupriya Agarwal
Anupriya Agarwal
Anupriya AgarwalOregon Health & Science University
  • 1 - 39

Datasets